{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:46:20Z","timestamp":1791773180432,"version":"4.3.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/ctg.2015.27","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T10:43:10Z","timestamp":1435833790000},"page":"e97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism"],"prefix":"10.14309","volume":"6","author":[{"given":"Kirstine Kobber\u00f8e","family":"S\u00f8gaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210317","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.114.009107","article-title":"30-year mortality after venous thromboembolism: a population-based cohort study.","volume":"130","author":"Sogaard","year":"2014","journal-title":"Circulation"},{"key":"R2-3-20210317","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gut.49.5.720","article-title":"Extrahepatic portal vein thrombosis: aetiology and determinants of survival.","volume":"49","author":"Janssen","year":"2001","journal-title":"Gut"},{"key":"R3-3-20210317","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses.","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-3-20210317","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study.","volume":"104","author":"Sogaard","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R5-3-20210317","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study.","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-3-20210317","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.","volume":"12","author":"Ogren","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R7-3-20210317","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","article-title":"Pulmonary embolism and deep vein thrombosis.","volume":"379","author":"Goldhaber","year":"2012","journal-title":"Lancet"},{"key":"R8-3-20210317","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-2006-951293","article-title":"Epidemiology and risk factors of venous thromboembolism.","volume":"32","author":"Ageno","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R9-3-20210317","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease.","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-3-20210317","first-page":"767","article-title":"Cirrhosis and chronic liver failure: part II. complications and treatment.","volume":"74","author":"Heidelbaugh","year":"2006","journal-title":"Am Fam Physician"},{"key":"R11-3-20210317","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.22341","article-title":"Comorbidity and survival of danish cirrhosis patients: a nationwide population-based cohort study.","volume":"48","author":"Jepsen","year":"2008","journal-title":"Hepatology"},{"key":"R12-3-20210317","first-page":"263","article-title":"The danish national hospital register. A valuable source of data for modern health sciences.","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"R13-3-20210317","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The danish civil registration system.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"R14-3-20210317","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: the danish national database of reimbursed prescriptions.","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"},{"key":"R15-3-20210317","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"Epidemiology. When an entire country is a cohort.","volume":"287","author":"Frank","year":"2000","journal-title":"Science"},{"key":"R16-3-20210317","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The danish register of causes of death.","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"R17-3-20210317","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines.","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"R18-3-20210317","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jclinepi.2009.03.018","article-title":"Venous thromboembolism discharge diagnoses in the danish national patient registry should be used with caution.","volume":"63","author":"Severinsen","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"R19-3-20210317","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/aje\/kwi309","article-title":"Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.","volume":"162","author":"Glynn","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R20-3-20210317","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R21-3-20210317","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"V, Beckerman H, Lankhorst GJ et al. How to measure comorbidity. A critical review of available methods.","volume":"56","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R22-3-20210317","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11239-006-5572-y","article-title":"The epidemiology of venous thromboembolism in the community: implications for prevention and management.","volume":"21","author":"Heit","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"R23-3-20210317","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCOUTCOMES.110.937441","article-title":"Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the worcester venous thromboembolism study.","volume":"3","author":"Spencer","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R24-3-20210317","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/01.CCM.0000171207.95319.B2","article-title":"Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors.","volume":"33","author":"Cook","year":"2005","journal-title":"Crit Care Med"},{"key":"R25-3-20210317","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.20360","article-title":"Venous thromboembolism prevention in the acutely ill medical patient: a review of the literature and focus on special patient populations.","volume":"79","author":"Pendleton","year":"2005","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"R26-3-20210317","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis.","volume":"56","author":"Fernandez","year":"2012","journal-title":"J Hepatol"},{"key":"R27-3-20210317","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"R28-3-20210317","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood-2014-07-551515","article-title":"How I treat splanchnic vein thrombosis.","volume":"124","author":"Ageno","year":"2014","journal-title":"Blood"},{"key":"R29-3-20210317","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.119.5.1489","article-title":"Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.","volume":"119","author":"Aggarwal","year":"2001","journal-title":"Chest"},{"key":"R30-3-20210317","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s005350050047","article-title":"Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality.","volume":"33","author":"Singh","year":"1998","journal-title":"J Gastroenterol"},{"key":"R31-3-20210317","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.510230615","article-title":"Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival.","volume":"23","author":"Zimmerman","year":"1996","journal-title":"Hepatology"},{"key":"R32-3-20210317","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","article-title":"Cirrhotic patients are at risk for health care-associated bacterial infections.","volume":"8","author":"Merli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-3-20210317","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.","volume":"35","author":"Fernandez","year":"2002","journal-title":"Hepatology"},{"key":"R34-3-20210317","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a danish population-based cohort study.","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"R35-3-20210317","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3748\/wjg.v20.i19.5737","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.","volume":"20","author":"Aggarwal","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R36-3-20210317","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1345\/aph.1Q726","article-title":"Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.","volume":"46","author":"Pincus","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R37-3-20210317","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1076029612461846","article-title":"Venous thromboembolism in cirrhosis.","volume":"20","author":"Yang","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"R38-3-20210317","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.thromres.2013.08.001","article-title":"Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: a systematic review and meta-analysis.","volume":"132","author":"Gomez Cuervo","year":"2013","journal-title":"Thromb Res"},{"key":"R39-3-20210317","first-page":"99","article-title":"Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry.","volume":"40","author":"Ageno","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"R40-3-20210317","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1022835207287","article-title":"Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology.","volume":"21","author":"Vestberg","year":"1997","journal-title":"J Med Syst"},{"key":"R41-3-20210317","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess charlson comorbidity index conditions in the population-based danish national registry of patients.","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"R42-3-20210317","first-page":"3741","article-title":"The national patient registry. evaluation of data quality.","volume":"157","author":"Mosbech","year":"1995","journal-title":"Ugeskr Laeger"},{"key":"R43-3-20210317","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0038-1635466","article-title":"Registration of diagnoses in the danish national registry of patients.","volume":"25","author":"Jurgensen","year":"1986","journal-title":"Methods Inf Med"},{"key":"R44-3-20210317","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2334-12-178","article-title":"Hepatitis C prevalence in denmark -an estimate based on multiple national registers.","volume":"12","author":"Christensen","year":"2012","journal-title":"BMC Infect Dis"}],"container-title":["Clinical and Translational Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ctg201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ctg201527","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01720094-201507000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ctg201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:10:10Z","timestamp":1786547410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01720094-201507000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1038\/ctg.2015.27","relation":{},"ISSN":["2155-384X"],"issn-type":[{"value":"2155-384X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}